Immediate transfusion in African children with uncomplicated severe anemia

<p>BACKGROUND</p> <p>The World Health Organization recommends not performing transfusions in African children hospitalized for uncomplicated severe anemia (hemoglobin level of 4 to 6 g per deciliter and no signs of clinical severity). However, high mortality and readmission rates s...

Full description

Bibliographic Details
Main Authors: Maitland, K, Kiguli, S, Olupot-Olupot, P, Walker, S
Other Authors: for the TRACT Group
Format: Journal article
Published: Massachusetts Medical Society 2019
_version_ 1797074394279837696
author Maitland, K
Kiguli, S
Olupot-Olupot, P
Walker, S
author2 for the TRACT Group
author_facet for the TRACT Group
Maitland, K
Kiguli, S
Olupot-Olupot, P
Walker, S
author_sort Maitland, K
collection OXFORD
description <p>BACKGROUND</p> <p>The World Health Organization recommends not performing transfusions in African children hospitalized for uncomplicated severe anemia (hemoglobin level of 4 to 6 g per deciliter and no signs of clinical severity). However, high mortality and readmission rates suggest that less restrictive transfusion strategies might improve outcomes.</p> <br/> <p>METHODS</p> <p>In this factorial, open-label, randomized, controlled trial, we assigned Ugandan and Malawian children 2 months to 12 years of age with uncomplicated severe anemia to immediate transfusion with 20 ml or 30 ml of whole-blood equivalent per kilogram of body weight, as determined in a second simultaneous randomization, or no immediate transfusion (control group), in which transfusion with 20 ml of whole-blood equivalent per kilogram was triggered by new signs of clinical severity or a drop in hemoglobin to below 4 g per deciliter. The primary outcome was 28-day mortality. Three other randomizations investigated transfusion volume, postdischarge supplementation with micronutrients, and postdischarge prophylaxis with trimethoprim–sulfamethoxazole.</p> <br/> <p>RESULTS</p> <p>A total of 1565 children (median age, 26 months) underwent randomization, with 778 assigned to the immediate-transfusion group and 787 to the control group; 984 children (62.9%) had malaria. The children were followed for 180 days, and 71 (4.5%) were lost to follow-up. During the primary hospitalization, transfusion was performed in all the children in the immediate-transfusion group and in 386 (49.0%) in the control group (median time to transfusion, 1.3 hours vs. 24.9 hours after randomization). The mean (±SD) total blood volume transfused per child was 314±228 ml in the immediate-transfusion group and 142±224 ml in the control group. Death had occurred by 28 days in 7 children (0.9%) in the immediate-transfusion group and in 13 (1.7%) in the control group (hazard ratio, 0.54; 95% confidence interval [CI], 0.22 to 1.36; P=0.19) and by 180 days in 35 (4.5%) and 47 (6.0%), respectively (hazard ratio, 0.75; 95% CI, 0.48 to 1.15), without evidence of interaction with other randomizations (P&gt;0.20) or evidence of between-group differences in readmissions, serious adverse events, or hemoglobin recovery at 180 days. The mean length of hospital stay was 0.9 days longer in the control group.</p> <br/> <p>CONCLUSIONS</p> <p>There was no evidence of differences in clinical outcomes over 6 months between the children who received immediate transfusion and those who did not. The triggered-transfusion strategy in the control group resulted in lower blood use; however, the length of hospital stay was longer, and this strategy required clinical and hemoglobin monitoring.</p>
first_indexed 2024-03-06T23:35:30Z
format Journal article
id oxford-uuid:6d846421-cfde-4285-b19a-c2c93d5b92c2
institution University of Oxford
last_indexed 2024-03-06T23:35:30Z
publishDate 2019
publisher Massachusetts Medical Society
record_format dspace
spelling oxford-uuid:6d846421-cfde-4285-b19a-c2c93d5b92c22022-03-26T19:18:18ZImmediate transfusion in African children with uncomplicated severe anemiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6d846421-cfde-4285-b19a-c2c93d5b92c2Symplectic Elements at OxfordMassachusetts Medical Society2019Maitland, KKiguli, SOlupot-Olupot, PWalker, Sfor the TRACT Group<p>BACKGROUND</p> <p>The World Health Organization recommends not performing transfusions in African children hospitalized for uncomplicated severe anemia (hemoglobin level of 4 to 6 g per deciliter and no signs of clinical severity). However, high mortality and readmission rates suggest that less restrictive transfusion strategies might improve outcomes.</p> <br/> <p>METHODS</p> <p>In this factorial, open-label, randomized, controlled trial, we assigned Ugandan and Malawian children 2 months to 12 years of age with uncomplicated severe anemia to immediate transfusion with 20 ml or 30 ml of whole-blood equivalent per kilogram of body weight, as determined in a second simultaneous randomization, or no immediate transfusion (control group), in which transfusion with 20 ml of whole-blood equivalent per kilogram was triggered by new signs of clinical severity or a drop in hemoglobin to below 4 g per deciliter. The primary outcome was 28-day mortality. Three other randomizations investigated transfusion volume, postdischarge supplementation with micronutrients, and postdischarge prophylaxis with trimethoprim–sulfamethoxazole.</p> <br/> <p>RESULTS</p> <p>A total of 1565 children (median age, 26 months) underwent randomization, with 778 assigned to the immediate-transfusion group and 787 to the control group; 984 children (62.9%) had malaria. The children were followed for 180 days, and 71 (4.5%) were lost to follow-up. During the primary hospitalization, transfusion was performed in all the children in the immediate-transfusion group and in 386 (49.0%) in the control group (median time to transfusion, 1.3 hours vs. 24.9 hours after randomization). The mean (±SD) total blood volume transfused per child was 314±228 ml in the immediate-transfusion group and 142±224 ml in the control group. Death had occurred by 28 days in 7 children (0.9%) in the immediate-transfusion group and in 13 (1.7%) in the control group (hazard ratio, 0.54; 95% confidence interval [CI], 0.22 to 1.36; P=0.19) and by 180 days in 35 (4.5%) and 47 (6.0%), respectively (hazard ratio, 0.75; 95% CI, 0.48 to 1.15), without evidence of interaction with other randomizations (P&gt;0.20) or evidence of between-group differences in readmissions, serious adverse events, or hemoglobin recovery at 180 days. The mean length of hospital stay was 0.9 days longer in the control group.</p> <br/> <p>CONCLUSIONS</p> <p>There was no evidence of differences in clinical outcomes over 6 months between the children who received immediate transfusion and those who did not. The triggered-transfusion strategy in the control group resulted in lower blood use; however, the length of hospital stay was longer, and this strategy required clinical and hemoglobin monitoring.</p>
spellingShingle Maitland, K
Kiguli, S
Olupot-Olupot, P
Walker, S
Immediate transfusion in African children with uncomplicated severe anemia
title Immediate transfusion in African children with uncomplicated severe anemia
title_full Immediate transfusion in African children with uncomplicated severe anemia
title_fullStr Immediate transfusion in African children with uncomplicated severe anemia
title_full_unstemmed Immediate transfusion in African children with uncomplicated severe anemia
title_short Immediate transfusion in African children with uncomplicated severe anemia
title_sort immediate transfusion in african children with uncomplicated severe anemia
work_keys_str_mv AT maitlandk immediatetransfusioninafricanchildrenwithuncomplicatedsevereanemia
AT kigulis immediatetransfusioninafricanchildrenwithuncomplicatedsevereanemia
AT olupotolupotp immediatetransfusioninafricanchildrenwithuncomplicatedsevereanemia
AT walkers immediatetransfusioninafricanchildrenwithuncomplicatedsevereanemia